Systemic review and meta-analysis: 10-day or 14-day sequential therapy versus 14-day triple therapy in the first line treatment of Helicobacter pylori infection

被引：0
|
作者：
Kuo, Chia-Chi [1 ]
Liou, Jyh-Ming [1 ]
Chen, Chieh-Chang [1 ]
Lee, Yi-Chia [1 ]
Chen, Mei-Jyh [1 ]
Wu, Ming-Shiang [1 ]
机构：
[1] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
duration; clarithromycin; metronidazole; resistance; efficacy;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1816
引用
下载
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [31] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacinbased triple therapy for second-line treatment of Helicobacter Pylori infection
    Kim, S.
    Roh, J.
    Park, M.
    Park, S.
    Moon, W.
    Kim, J.
    Jung, K.
    Seol, S.
    HELICOBACTER, 2016, 21 : 142 - 142
  • [32] Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study
    Mori, Hideki
    Suzuki, Hidekazu
    Matsuzaki, Juntaro
    Tsugawa, Hitoshi
    Fukuhara, Seiichiro
    Miyoshi, Sawako
    Hirata, Kenro
    Seino, Takashi
    Matsushita, Misako
    Nishizawa, Toshihiro
    Masaoka, Tatsuhiro
    Kanai, Takanori
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (03) : 380 - 387
  • [33] 14-day high-dose dual therapy is equally as good as 14-day clarithromycin based standard triple therapy in first line H. pylori eradication treatment
    Leow, Alex Hwong-Ruey
    Goh, Khean-Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 363 - 363
  • [34] A 14-day course of triple therapy is superior to a 10-day course for the eradication of Helicobacter pylori: A Canadian study conducted in a 'real world' setting
    Chen, Yen-I
    Fallone, Carlo A.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 29 (08) : E7 - E10
  • [35] Neither 10-nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication
    Warrington, Emanuel
    Lopez-Roman, Orlando
    Tirado-Montijo, Rafael
    Urbina, Rafael
    Cruz-Correa, Marcia
    Toro, Doris H.
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2016, 35 (04) : 203 - 208
  • [36] 14-day high-dose dual therapy versus 14-day clarithromycin based standard triple therapy: A promising alternative therapy?
    Leow, Alex Hwong-Ruey
    Goh, Khean Lee
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 69 - 69
  • [37] The effect of Saccharomyces boulardii as an adjuvant to the 14-day triple therapy for eradication of Helicobacter pylori
    Lee, J. Y.
    Choi, S. P.
    Park, J. H.
    Shin, J. W.
    Joo, Y. H.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 257 - 257
  • [38] Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'
    Losurdo, G.
    Leandro, G.
    Principi, M.
    Giorgio, F.
    Montenegro, L.
    Sorrentino, C.
    Ierardi, E.
    Di Leo, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (10) : 1112 - 1120
  • [39] First-line therapy for H. pylori infection with sequential therapy: comparison between 10-and 14-day regimen
    Portincasa, Piero
    Scaccianoce, Giuseppe
    Zullo, Angelo
    Fiorini, Giulia
    De Francesco, Vincenzo
    Vassallo, Roberto
    Urban, Flavia
    Monica, Fabio
    Mogavero, Giuseppe
    Amato, Armando
    Vaira, Dino
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 217 - 217
  • [40] EFFICACY OF 7-DAY AND 10-DAY OF VAB (VONOPRAZAN, AMOXICILLIN, AND BISMUTH SUBSALICYLATE) VERSUS 14-DAY STANDARD TRIPLE THERAPY FOR FIRST-LINE HELICOBACTER PYLORI ERADICATION: A MULTICENTER RANDOMIZED CONTROLLED TRIAL
    Phetkee, Thitiwat
    Anansawat, Veerayut
    Suksamai, Anuchit
    Songserm, Sukhum
    Yongwatana, Kachonsak
    GASTROENTEROLOGY, 2023, 164 (06) : S375 - S376
12345